Legal & General Group
ACHV icon

Legal & General Group’s Achieve Life Sciences ACHV Stock Holding History

Legal & General Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,484
Closed -$9.3K – 3418
2025
Q1 		$9.3K Hold
3,484
– – ﹤0.01% 3186
2024
Q4 		$12.3K Hold
3,484
– – ﹤0.01% 3204
2024
Q3 		$16.5K Hold
3,484
– – ﹤0.01% 3124
2024
Q2 		$16.4K Buy
+3,484
New +$16.8K ﹤0.01% 3105

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's ACHV Position: Q2 2025 in Review

Legal & General Group sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 3,484 shares — an estimated $9.3K sold.

Legal & General Group first reported a position in ACHV in Q2 2024 and held it in 4 quarters. The position peaked at $16.5K in Q3 2024. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • Legal & General Group reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 3,484 Achieve Life Sciences shares in Q2 2025, an estimated $9.3K.
  • Legal & General Group first reported a position in Achieve Life Sciences in Q2 2024 and held it in 4 quarters.
  • Legal & General Group's Achieve Life Sciences position peaked at $16.5K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.